# A Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers

> **NCT01870245** · PHASE1 · TERMINATED · sponsor: **Achaogen, Inc.** · enrollment: 4 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** ACHN-975
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01870245
- **Lead sponsor:** Achaogen, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-05
- **Primary completion:** 2013-06
- **Final completion:** —
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2013-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01870245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01870245, "A Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01870245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*